The creation of consistent and high value engagements with individuals across their digital and in-person engagements will enable these providers to both attract and retain consumers in the rapidly evolving healthcare ecosystem.
At its first investor day since the start of the pandemic, CVS Health detailed plans to open primary care centers and integrate them with its other health services. At the same time, CVS plans to close 900 stores as it focuses on this new strategy.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
CVS plans to use more of Microsoft’s cloud services, and also plans to work with the company to develop personalized health services focused on consumers. The partnership comes as CVS looks to build its digital presence and close a portion of its pharmacies.
The company launched a new health division, and has doubled down on its plans to open primary care clinics with VillageMD. It faces big competitors in CVS and Walmart, and it’ll take time to see if its new strategy pays off.
The company will close 300 stores per year starting next spring. As CVS emphasizes health services as part of its strategy, it also plans to change some of its locations into primary care clinics.
CVS recently launched a virtual primary care plan through a partnership with Teladoc, and is redesigning its stores to offer a broader array of health services. In an earnings call, CEO Karen Lynch said the company is starting to get traction with its new insurance plan designs.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Transcarent, which is works with companies to steer their employees toward higher-quality, lower-cost care, struck a partnership with Walmart. It will offer Walmart’s health services, including its prescription prices, to self-insured companies.
Walgreens plans to invest a total of $5.2 billion in VillageMD, up from its original plans to buy a $1 billion stake in the primary care company. It’s part of a broader consumer health strategy Walgreens plans to use to grow its business in the future.
Through a string of recent acquisitions, Best Buy has been building out its health business, with a focus on consumer technology and support for seniors. With its acquisition of Current Health, the company is making a bet that demand for remote patient monitoring will continue to increase.
CVS lowered its guidance for vaccines after seeing vaccinations decline from their mid-April heights. But more people are coming in for first doses after the Delta variant has caused Covid-19 cases to rise again.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
As part of a partnership with primary care provider VillageMD, Walgreens plans to open 29 clinics in Texas this year. In total, the companies plan to open at least 600 clinics over the next four years.
Intermountain Healthcare plans to close 25 of its retail pharmacies, and will transfer those prescriptions to CVS Pharmacy starting next month. The change will affect about 250 employees.
Walmart struck a deal with Novo Nordisk to offer a heavily discounted, private-label version of its fast-acting analog insulin. But it still doesn’t solve the pricing problems patients have faced, with insulin costs skyrocketing in recent years.
Walmart is buying telehealth provider MeMD, adding virtual urgent care and therapy visits. Walmart said the deal would complement the in-person health centers it is building in some of its stores.
After months of frenetic activity to get vaccines to people as quickly as possible, CVS is seeing the number of appointments decline. The retail pharmacy chain is still including a potential pediatric vaccine in its estimates, it told investors.